Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Marx, Nikolaus; Deanfield, John E.; Mann, Johannes F. E.; Arechavaleta, Rosario; Bain, Stephen C.; Bajaj, Harpreet S.; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L.; Buse, John B.; Davicevic-Elez, Zaklina; Desouza, Cyrus; Emerson, Scott S.; Engelmann, Mads D. M.; Hovingh, G. Kees; Inzucchi, Silvio E.; Jhund, Pardeep S.; Mulvagh, Sharon L.; Pop-Busui, Rodica; Poulter, Neil R.; Rasmussen, Soren; Tu, Shih-Te; McGuire, Darren K.

Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Autor(en):

Marx, Nikolaus; Deanfield, John E.; Mann, Johannes F. E.; Arechavaleta, Rosario; Bain, Stephen C.; Bajaj, Harpreet S.; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L.; Buse, John B.; Davicevic-Elez, Zaklina; Desouza, Cyrus; Emerson, Scott S.; Engelmann, Mads D. M.; Hovingh, G. Kees; Inzucchi, Silvio E.; Jhund, Pardeep S.; Mulvagh, Sharon L.; Pop-Busui, Rodica; Poulter, Neil R.; Rasmussen, Soren; Tu, Shih-Te; McGuire, Darren K.

Tübinger Autor(en):

Birkenfeld, Andreas L.

Erschienen in:

Circulation (2025), Bd. 151, H. 23, S. 1639-1650

Verlagsangabe:

Philadelphia : Lippincott Williams & Wilkins

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1161/CIRCULATIONAHA.125.074545

ISSN:

0009-7322